Brachytherapy or Surgery? A Composite View
As treatments for prostate cancer, brachytherapy and surgery share logistics in that they both involve a procedure that may be performed in one intervention. Beyond that, one sees similarities and differences depending on the point of comparison being examined. The ideal dataset to use for such a comparison would be from a well-done randomized trial. More »
Age dictates risk when neoadjuvant hormone therapy is added to prostate brachytherapy
The risks associated with neoadjuvant hormonal therapy may outweigh the benefits of its use in conjunction with brachytherapy in some older men with prostate cancer, according to research from the radiation oncology program at Boston’s Harvard Medical School. More »
SAVI applicator removes obstacles associated with brachytherapy
TORONTO—Studies out of the University of California, San Diego, have demonstrated that the SAVI radiation device offers coverage of the breast cancer tumor bed while sparing normal tissue from radiation. More »
Brachytherapy improves cancer treatment in augmented breasts
Targeted radiation of breast cancer reduces treatment time from six and a half weeks to five days, while reducing pain and improving cosmetic outcome, according to a study presented at the RSNA meeting. More »
Brachytherapy improves treatment in augmented women
CHICAGO—Targeted radiation of breast cancer after lumpectomy reduces treatment time from six and a half weeks to five days, while reducing pain and improving cosmetic outcome, according to a study presented at RSNA 2008 (abstract SSC19-02). More »
Low toxicity with SAVI breast brachytherapy
Using the SAVI applicator for breast brachytherapy, 14 of 18 patients experienced no skin reactions, and the other four had only minor reactions that resolved quickly, Constantine Mantz, MD, reported at the 25th Annual Miami Breast Cancer Conference. Dr. Mantz, a radiation oncologist at 21st Century Oncology, Inc. Fort Myers, Florida, said that the overall cosmetic outcomes with SAVI were rated excellent. More »
Good results with multicatheter brachytherapy APBI
Use of accelerated partial breast irradiation (APBI) with multicatheter brachytherapy to treat resected early-stage breast cancer is associated with good early outcomes in terms of local control, adverse effects, and cosmesis More »
Brachytherapy as effective in younger as in older men
Compared with older men, younger men have a similarly high rate of biochemical control of localized prostate cancer when treated with brachytherapy and should therefore be offered this treatment option More »
AMA approves CPT code for Axxent electronic brachytherapy
AMA approves CPT code for Axxent electronic brachytherapy More »
Electronic Brachytherapy System New Option for Breast Cancer RT
Xoft, Inc.'s Axxent Electronic Brachytherapy System for accelerated partial breast irradiation (APBI) recently had its first clinical use in two lumpectomy patients treated at WellStar Kennestone Hospital. More »
Showing 1 - 10 of 60 results.
Page of 6